Don't sweat the lingo. They have to set the parameters for the Phase 3 trial(studies). The Phase 2 mentioned is for another possible use of the same drug.
Man, I've been in since the split and watched it just vasilate back and forth. Now it is ready to roll.
Another plus for me is the scarce PRs - but that's a double edged sword because it means we remain under lots of radars.
FYI - I joined that MB and was reading your BIO thread, still peeking around in there for the time being.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.